Concepedia

Author

Yue Zhuo

Guangzhou Medical UniversityORCID

Also Known As

Yue ZHUO, Yue Zhuo

26

Publications

217

Citations

9

H-Index

26

Concepts

All Affiliations

Guangzhou Medical UniversityGuangzhou University of Chinese MedicineState Key Laboratory of Respiratory DiseaseFirst Affiliated Hospital of Guangzhou Medical UniversityWuhan Botanical Garden
YZ

About

Yue Zhuo is an author at Guangzhou Medical University specializing in liver physiology, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

62

2

Biochemistry

3

3

62

3

Hepatology

2

2

43

4

Health Sciences

1

1

21

5

Natural Sciences

1

1

19

Yue Zhuo

×

7

Publications

123

Citations

7

H-Index

YearCitations

Sp1 S-Sulfhydration Induced by Hydrogen Sulfide Inhibits Inflammation via HDAC6/MyD88/NF-κB Signaling Pathway in Adjuvant-Induced Arthritis

Meng Li, Wei Hu, Ran Wang,

Antioxidants

2022

27

Strategy for Hepatotoxicity Prediction Induced by Drug Reactive Metabolites Using Human Liver Microsome and Online 2D-Nano-LC-MS Analysis

Yue Zhuo, Jian‐Lin Wu, Xiaojing Yan,

Analytical Chemistry

2017

22

Integrated Proteomics, Biological Functional Assessments, and Metabolomics Reveal Toosendanin-Induced Hepatic Energy Metabolic Disorders

Xiaojing Yan, Yue Zhuo, Xiqing Bian,

Chemical Research in Toxicology

2019

21

Hepatotoxic evaluation of toosendanin via biomarker quantification and pathway mapping of large-scale chemical proteomics

Yue Zhuo, Yida Zhang, Meng Li,

Food and Chemical Toxicology

2021

19

Characterization of covalent protein modification by triclosan in vivo and in vitro via three-dimensional liquid chromatography-mass spectrometry: New insight into its adverse effects

Meixian Liu, Na Li, Yida Zhang,

Environment International

2020

12

Systems pharmacology-based mechanism exploration of Acanthopanax senticosusin for Alzheimer's disease using UPLC-Q-TOF-MS, network analysis, and experimental validation

Yue Zhuo, Xiaomei Fu, Qiyao Jiang,

European Journal of Pharmacology

2023

12

Analysis on the risk of myasthenia gravis related to immune checkpoint inhibitors based on the <scp>US FDA</scp> Adverse Event Reporting System

Hui Wang, Xiaolei Ren, Yue Zhuo,

Cancer Medicine

2023

10

Page 1